Rabbit anti-idiotypic antibodies (aId Ab) were prepared against five murine monoclonal antibodies (mAb) specific for the rabies virus glycoprotein. Four of the mAb were directed against three known, type-specific, neutralizing sites on the glycoprotein, and the other mAb was directed against a topographically uncharacterized, nonneutralizing epitope. An absence of significant cross-reactivity among the aId Ab for heterologous mAb suggested that the aId Ab were highly specific for unique variable region determinants. The binding of three of the five aId Ab to their homologous mAb could be inhibited by rabies virus-soluble glycoprotein, suggesting that the aId Ab possessed subpopulations similar or adjacent to the antigen-binding site of the mAb. Two of the five aId Ab injected into mice elicited a specific virus-neutralizing antibody response. Mechanisms to account for the induction of the virus-neutralizing antibody by aId Ab are discussed.
The sequence of amino acids in the variable regions of both heavy (VH) and light (VL) chains of immunoglobulin produces a conformation in the antigen-binding site that allows interaction of the antibody with a specific antigen. Injection of immunoglobulin into a heterologous host animal gives rise to anti-xenotypic antibodies (specific for species), anti-isotypic antibodies (specific for the class of antibody), and anti-idiotypic antibodies (aId Ab; specific for the variable region). Two functional classes of aId Ab can exist, one which reacts with the antigen-combining site and another which is localized on the VH chain or the VL chain or both (framework determinants) (15) .
Heterologous aId Ab have been useful in studies of immunodominance (2, 22) , antibody diversity (30) , and cell surface binding (24, 27) . The operational theory in the latter type of studies is that a subset of the ald Ab represents a conformational homolog of the antigen to which the idiotype binds and thus exhibits binding specificity similar to this antigen.
We investigated the abilities of aId Ab made against various monoclonal antibodies (mAb) to reconstruct the epitopes of rabies virus glycoprotein. This glycoprotein is responsible for many of the important biological properties of rabies virus, including the induction of virusneutralizing antibodies (VNA) (8) , the site of antigenic drift (19, 35) , the induction of cellmediated immunity (33) , and attachment to cell surface receptors (25; Wunner and Reagan, manuscript in preparation). Precisely which portion of the glycoprotein is responsible for each of these functions is unknown at present. Lafon et al. (19) have recently presented a functional epitope map for the challenge virus standard (CVS) strain of rabies virus glycoprotein, which suggests the existence of at least three major antigenic sites for type-specific VNA.
In this study we prepared aId Ab against five anti-glycoprotein mAb (aG mAb). These aG mAb were directed against the known functionally defined antigenic sites of rabies virus glycoprotein, and all but one strongly neutralized virus infectivity. The derived aId Ab were specific for the idiotypic regions of their respective hybridoma-derived antibodies, and two of the five elicited VNA in mice. The VNA produced were specific for rabies virus and failed to neutralize a variant virus selected by the original aG mAb. This demonstrates that an otld Ab can mimic the antigenic structure of a viral protein well enough to induce a neutralizing antibody.
MATERIALS AND METHODS
mAb. Anti-rabies virus glycoprotein mAb 509-6, 101-1, 507-1, and 719-3 have been described previously (19, 35) (Table 1) . aG mAb 1104-2 was obtained from an additional fusion of splenocytes from rabies virus-immunized BALB/c mice with variant 653 of P3x63Ag8 mouse myeloma cells (17) by methods described elsewhere (34) . The anti-glycoprotein-secreting hybridoma cells were selected and cloned by limiting dilution, and ascites fluids were prepared as previously described (34) . Anti-rabies virus nucleo-RABIES VIRUS aId Ab (19) . b Determined by the RIA, using specific rabbit anti-mouse isotype serum (12) . C RIA with strain ERA virus as the target antigen. The endpoint was determined to be the reciprocal of the highest dilution yielding reactivity that was 10%o above the background level.
d Virus neutralization using a 20-h rapid fluorescent focus inhibition test with strain ERA virus. The neutralization endpoint was determined as the reciprocal of the highest serum dilution which reduced the number of infected cells by 50%o.
e For yl, myeloma protein from P3x63Ag8 cells.
f The corresponding tissue culture fluid was also negative for VNA at a 1:9 dilution.
were isolated by similar techniques from Kelev virusimmunized BALB/c mice.
Viruses. Stocks of rabies virus strains ERA and CVS were propagated in BHK-21 cells by standard methods (31) . The rabies virus antigenic variants ERA RV194-2 and RV509-6 have been described previously (11) and represent viruses which are resistant to neutralization by aG mAb 194-2 and 509-6, respectively. Rabies soluble glycoprotein (GJ) was purified from viriondepleted culture fluids by immunoadsorbent chromatography, as previously described (10) .
Antibody purification. All aG mAb were purified from ascites fluids. Antibodies of the y2, isotype were diluted approximately 1:30 with 0.2 M Britton-Robinson buffer (pH 8.0), which consisted of 0.029 N citric acid monohydride, 0.058 N potassium phosphate (monobasic), 0.029 N barbital, and 0.087 N boric acid (30) . This preparation was passed through a 0.45-,um membrane filter (Nalgene Labware Div., Nalge/Sybron Corp., Rochester, N.Y.) and then over a protein A-Sepharose 4B adsorption column (Pharmacia Fine Chemicals, Inc., Piscataway, N.J.). The column was washed with 30 ml of Britton-Robinson buffer (pH18.0) before antibody was eluted with Britton-Robinson buffer at pH 3.0. aG mAb of the yl isotype were first precipitated with sodium sulfate at a final concentration of 18% (wt/vol). The immunoglobulin fraction was dissolved and dialyzed in Britton-Robinson buffer (pH 8.0) and then passed over the protein A-Sepharose column as described above. Immunoglobulin eluted from the column was detected by a radioimmunoassay (RIA), using strain ERA virus as the antigen (9) . The antibodies were concentrated by vacuum dialysis against phosphate-buffered saline (pH 7.4). Protein concentrations were determined by using bovine serum albumin as the standard (6) .
aId Ab. aId Ab were prepared by the method of Staudt and Gerhard (30) . Briefly, female New Zealand white rabbits were injected subcutaneously in multiple sites along the mammary chain with 300 ,ug of protein A-Sepharose-purified mAb emulsified in Freund complete adjuvant. Two intramuscular boosters of 100 ,ug of antibody in phosphate-buffered saline were given on days 7 and 30, and sera were collected 10 days later. Each anti-idiotypic antiserum was made specific for idiotype regions by passage over a Sepharose 4B column to which Yi or y,u anti-rabies nucleocapsid mAb were coupled. The effluent from such columns contained the antibodies that were reactive with the idiotypic determinants. Antibodies to constant regions were eluted from the anti-nucleocapsid immunoadsorbent column with 0.1 M diethylamine (pH 11.5). Immunoglobulin G (IgG) from each aId Ab was isolated by protein A-Sepharose chromatography as described above.
RIA. A solid-phase RIA was used to measure the binding of aId Ab to fixed mAb. Individual mAb were diluted (1:1,000 to 1:16,000, depending on the ascites fluid concentration) in carbonate-bicarbonate buffer (pH 8.9), and 25-,ul portions were added to wells of polyvinyl microtiter plates (Dynatech Laboratories). These antibodies were allowed to dry in the wells by overnight incubation at 37°C. The free binding sites on the wells were blocked for at least 1 h with 10% agamma horse serum (GIBCO Laboratories, Grand Island, N.Y.) dissolved in phosphate-buffered saline containing 0.08% sodium azide. Dilutions (25 ,ul) of aId Ab were added, and after 1 h at room temperature the plates were washed extensively. Bound aId Ab were detected by adding 25 ,ul (30,000 cpm) of 125i-labeled goat anti-rabbit IgG (Cappel Laboratories, Downingtown, Pa.) labeled by the iodogen method (21) and incubating the preparations for an additional 1 h at room temperature. All dilutions of aId Ab or radiolabeled probe were made in 10o agamma horse serum dissolved in phosphate-buffered saline containing 0.08% sodium azide. The plates were washed free of unbound probe, and the radioactivity bound to individual wells was measured with a gamma counter. All data represent the mean values of duplicate or triplicate assays.
Virus neutralization assay. The levels of VNA in immunized mice were determined by a modification of the rapid fluorescence focus inhibition test (29 chosen because of their isotypes (enabling purification by protein A-Sepharose chromatography) and binding sites on the rabies virus glycoprotein, as defined by functional epitope mapping (19) . Four of the mAb strongly neutralized viral infectivity. One other mAb, aG mAb 1104-2, was selected because it demonstrated excellent binding to strain ERA virus but poor neutralization. The characteristics of the mAb selected are summarized in Table 1 . Each mAb was purified from ascites fluid and injected into rabbits to produce a hyperimmune serum as described above. Each hyperimmune rabbit serum was extensively adsorbed against purified mAb having the identical isotype but unrelated specificity (anti-rabies nucleocapsid mAb 515-3 or 389-1) to eliminate antibodies to constant region determinants. The success of this procedure was monitored by the RIA, and typical results are shown for aId Ab 101-1 in Fig. 1 . Before adsorption, the antiserum to aG mAb 101-1 reacted equally well with either aG mAb 101-1 or an anti-nucleocapsid mAb having an identical isotype, suggesting a strong reaction to common determinants. Immunoglobulin which was eluted from the anti-nucleocapsid immunoadsorbent column reacted strongly with both antigens, indicating that it contained the crossreactive material. In contrast, the material that passed through the column reacted only with the aG mAb and therefore contained the aId Ab. The reactivity of ald Ab 101-1 with nonidiotypic determinants was the maximum observed with any of the aId Ab preparations and was considered to be negligible. Characterization of aId Ab. To demonstrate the specificity of the aId Ab and to determine whether cross-reactive idiotypes existed among the various aG mAb, each ald Ab preparation was titrated against homologous and heterologous mAb in an RIA. Table 2 clearly shows that each ctd Ab was specific for its homologous mAb.
Although each ald Ab reacted only with the immunizing mAb, the proportion of the ald Ab response which was a response to the framework or antigen-binding sites of the mAb was not clear. Therefore, we devised a competition RIA to test the ability of rabies virus glycoprotein to prevent the interaction between idiotype and anti-idiotype (7, 28) . The rabies G, was used as the competing antigen. As shown in Fig. 2 , the binding of three of the five aId Ab to their corresponding aG mAb was inhibited by Gs.
Maximum inhibition varied from 20 to 50% with as much as 6 ,ug of Gs per ml, but at least a 15% reduction was observed with as little as 0.75 ,ug of G, per ml. The inability to inhibit the binding of aId Ab totally was a clear indication that both framework and antigen-combining site specificities were present in three of the polyclonal ald Ab sera. The absence of any significant binding inhibition by G, for aId Ab 101-1 or aId Ab 719-3 suggested a minor population or no population of antigen-binding specificities in these sera.
Preparation of anti-aId Ab. aId Ab reactive with the antigen-combining sites of aG mAb may contain subpopulations which mimic the viral epitopes recognized by these aG mAb. Therefore, inoculation of animals with aId Ab may induce antibodies which react with native rabies virus glycoprotein. Accordingly, protein A-Sepharose-purified ald IgG was used to immunize mice, and the derived sera were tested for neutralization of rabies virus by the rapid fluorescent focus inhibition test ( same as the pattern observed with the respective anti-aId Ab sera. Strain CVS of rabies virus bound both aG mAb 509-6 and aG mAb 1104-2 (data not shown), and Table 3 shows that strain CVS was neutralized by both anti-aId Ab 509-6 and anti-cId Ab 1104-2. On the other hand, a variant of strain ERA, RV 509-6, which possessed a mutation in the 509-6 epitope resulting in the loss of binding or neutralizing activity by aG mAb 509-6 (19), was not neutralized by antiaId Ab 509-6. Another neutralization-resistant variant, RV 194-2, was effectively neutralized by anti-aId Ab 509-6. Previous results demonstrated that the antigenic sites recognized by aG mAb 509-6 and aG mAb 194-2 are totally independent (19) . These data show that anti-aId Ab 509-6 reacts solely with the epitope which is recognized by aG mAb 509-6, and thus this epitope was simulated by ald Ab 509-6.
The level of complexity of the structural requirements for virus neutralization is demonstrated by the results obtained with anti-aId Ab 1104-2. aG mAb 1104-2 was originally chosen for this work because of its lack of neutralizing activity, yet anti-aId Ab 1104-2 contained VNA. Even though aG mAb 1104-2 bound well to RV 509-6 (data not shown), this variant virus was not neutralized by anti-aId Ab 1104-2. As expected, anti-aId Ab 1104-2 neutralized RV 194-2. A more direct test of anti-aId Ab 1104-2 neutralization specificity was not possible because nonneutralizing aG mAb 1104-2 could not be used to select resistant variant viruses. The titer of VNA in either group of mice was not sufficient to protect against a lethal intracerebral challenge with virus strain CVS. DISCUSSION Studies involving purified rabies virus glycoprotein or peptide fragments of glycoprotein have been hampered by hydrophobicity and destruction of native glycoprotein conformation. Thus, a soluble probe that imitates the secondary or tertiary conformation of glycoprotein in its native form would be of obvious benefit. aId Ab were prepared against various aG mAb with the intention of generating a population of internal image antibodies (16) which would mimic the epitope on native glycoprotein to which the aG mAb bound. Below we discuss the likelihood of such an event and also suggest a second mechanism for the induction of VNA.
The data in Fig. 1 and Table 2 indicate that the aId Ab obtained were highly specific for their homologous mAb. The absence of significant cross-reactions among the idiotypic regions of the mAb (Table 2 ) was not surprising since (i) the mAb selected bound to nonidentical areas on the glycoprotein epitope map (19) and (ii) other workers have found a low incidence of crossreacting idiotypes among mAb directed to the same antigenic site but derived from different fusions (30) . From Fig. 2 , which demonstrates the competition between ald Ab and Gs for binding to mAb, we conclude that only a fraction of the aId Ab actually possessed Gs-modifiable reactivity with mAb (the operative definition of antigen-binding site specificity). We realize that this competition may be the result of steric inhibition rather than true conformational homology (20) . Nevertheless, if or when an internal image antibody is generated, it should be structurally similar, if not identical, to the epitope bound by the original mAb and thus trigger the expression of idiotype-specific B-cell populations (3, 4) . The fact that two aId Ab were able to induce VNA is consistent with the hypothesis that there was a conformation in the aId Ab which was similar to the viral epitope. It is clear, at least in the case of anti-aId Ab 509-6, that the VNA produced was identical to the monoclonal specificity of aG mAb 509-6. Like aG mAb 509-6, the VNA produced reacted only with the 509-6 epitope present on strain ERA, CVS, and RV 194-2 viruses; it did not react with RV 509-6.
Precisely why only two of five aId Ab were successful in eliciting a neutralizing response can only be a matter for speculation. It may be that of the three nonneutralizing antibody responses, aId Ab 101-1 and aId Ab 719-3 had only very minor proportions of their aId Ab repertoires directed against the antigen-binding site (Fig. 2) . If this were the case, the chances of detecting a neutralizing response would be low. On the other hand, aId Ab 507-1 possessed the highest proportion of antigen-binding site specificities (Fig. 2 ), yet it failed to induce VNA. We cannot rule out the possibility that immunization of mice with this aId Ab resulted in the stimulation of suppressor T cells (12) , the deletion of B cells possessing the relevant idiotype (1, 23) , or the induction of antibodies with too low an avidity to neutralize virus. Studies have shown that the induction or suppression of idiotopepositive B cells can depend upon the antibody class and the dose of aId Ab (12, 18) . We also cannot rule out the possibility that aId Ab 101-1, oId Ab 719-3, and odd Ab 507-1 failed to induce VNA not because of the amount of internal image antibodies present, but rather because of an absence of B cells bearing the appropriate idiotopes in the repertoire of ICR mice.
Antigen mimicry by aId Ab does not explain all of our data, and indeed, the existence of internal image antibodies has been questioned (5, 20) . If aId Ab 1104-2 had successfully reconstructed the epitope recognized by aG mAb 1104-2, one would expect it to induce a nonneutralizing antibody in mice similar to aG mAb 1104-2. Instead, anti-aId Ab 1104-2 possessed the highest VNA titer and a neutralization pattern similar to that of anti-ald Ab 509-6.
However, the hypothesis that the 509-6 and 1104-2 epitopes are related is unsupported by two lines of evidence. First, aId Ab 1104-2 did not cross-react with aG mAb 509-6 (Table 2) , and therefore aId Ab 1104-2 was not identical to aId Ab 509-6. Second, aG mAb 1104-2 bound well to RV 509-6, which lacked the 509-6 epitope. Therefore, it is apparent, that aId Ab 1104-2 has some properties which distinguish it from the epitope recognized by mAb 1104-2.
It has been shown previously that mice treated in vivo with xenogeneic aId Ab can express an antibody found in their sera that can inhibit the interaction of idiotope with odd Ab (2, 3, 13) .
Studies with monoclonal anti-otd Ab have shown that the idiotope expressed by the antiodd Ab can differ from the original idiotope, but these typically fail to bind antigen (4). Our finding of an alteration of binding specificity may suggest an alternative explanation for the induction of VNA. It is possible that the stimulation of idiotope-positive B cells may not depend on an encounter with an internal image antibody but rather on an encounter with an oad Ab specific for a framework sequence. This framework sequence may represent a cross-reactive idiotype or precursor B cells, which are preferentially utilized in the generation of antibodies specific for rabies virus glycoprotein. Upon clonal expansion and somatic diversification, the fine specificity of the secreted antibodies may vary (30) . Since only a neutralizing antibody would be detected in the functional test used to assay the effectiveness of anti-ald Ab production, aId Ab 1104-2 derived from a nonneutralizing mAb would appear to have induced VNA. This argument is weakened, however, by the absence of detectable cross-reactive idiotypes among the mAb (Table 2) .
Current studies are aimed at distinguishing between the internal image and framework hypotheses for induction of VNA by determining the usefulness of the ald Ab as cell surface probes, a particular function of internal image antibodies (24, 27) . Sacks et al. (26) also have reported evidence for antigen-independent immunization in ald Ab derived from anti-Trypanosoma mAb. We believe that our findings support the idea that immunization with aId Ab can induce specific virus-neutralizing responses, as has been theorized by other workers (1, 14) . Our findings also provide a basis for speculation on the incidence of naturally occurring aId Ab in humans treated with rabies immune globulin and its potential effect on the immune regulation network.
